Cooper Companies (The)
Large Cap · Healthcare · Medical Instruments & Supplies
$77.25+$1.50 (+1.97%)
Cooper Companies (The)
Large Cap · Healthcare · Medical Instruments & Supplies
$77.25+$1.50 (+1.97%)
Stock analysis
Get the AI take on COO
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$58.89
High$89.83
Today $77.25
RSI (14)
70.0Neutral
03070100
Overall score
51/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$66
Current price
$77.25
Median target
$85
Highest
$92
LowHigh
Operating Record
Revenue
What's working
- Forward P/E: Investors aren't pricing in much earnings growth, so there's room to be pleasantly surprised.
- Debt / equity: Light borrowing means a rough patch wouldn't threaten the balance sheet.
What to watch
- Debt exceeds cash by $2.6B, increasing balance-sheet pressure, a warning sign.
- ROIC: Capital plowed back into the business isn't earning much for its trouble.
What the market charges
Forward P/E
Favorable · 23% below avg
16.10x
Price / sales
Reasonable · Priced reasonably against its revenue
3.51x
Price / FCF
Reasonable · Priced a bit rich against its cash flow
26.09x
EV / EBITDA
Reasonable · Operating earnings make this price a stretch but plausible
19.68x
How efficiently it compounds
ROIC
Weak · Struggling to earn much on the capital it uses
2.6%
ROE
Needs attention · Unfavorable
2.9%
Debt / equity
Favorable · 0.30 - strong leverage
0.33x
Current ratio
Reasonable · Just enough on hand to cover near-term bills
1.27x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $14.86B | 64.3 | +6.1% | 51 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |